James A. Thomson

James A. Thomson
Name	James A. Thomson
Birth date	20 December 1958
Birth place	Oak Park, Illinois
Nationality	American
Fields	Developmental biology, Cell biology
Workplaces	University of Wisconsin–Madison, Morgridge Institute for Research
Alma mater	University of Illinois Urbana-Champaign, University of Pennsylvania
Known for	Isolation of human embryonic stem cells, derivation of induced pluripotent stem cells
Awards	Shaw Prize (2011), Albany Medical Center Prize (2011)

James A. Thomson is an American biologist whose pioneering work fundamentally reshaped the fields of regenerative medicine and developmental biology. He is best known for first isolating and culturing human embryonic stem cells and, later, for leading one of the teams that first created induced pluripotent stem cells from human somatic cells. His research, conducted primarily at the University of Wisconsin–Madison and the affiliated Morgridge Institute for Research, has provided foundational tools for studying human development, modeling diseases, and developing potential cell-based therapies.

Early life and education

Born in Oak Park, Illinois, Thomson developed an early interest in science. He pursued his undergraduate education at the University of Illinois Urbana-Champaign, where he earned a degree in biophysics. He then moved to the University of Pennsylvania for his doctoral studies, completing a PhD in veterinary medicine and molecular biology in 1985. His postdoctoral fellowship was conducted at the Oregon National Primate Research Center, focusing on early mammalian development in non-human primates, which laid crucial groundwork for his future stem cell research.

Research and career

Following his postdoctoral work, Thomson established his independent laboratory at the University of Wisconsin–Madison in the Wisconsin National Primate Research Center. His early career focused on understanding the biology of pluripotency and the signals that control early cell fate decisions in embryos from species like the rhesus monkey. This expertise in primate embryology positioned him uniquely to tackle one of the most significant challenges in modern biology: the derivation of pluripotent stem cells from human embryos. His research has been supported by major grants from the National Institutes of Health and private organizations like the Charlotte Geyer Foundation.

Human embryonic stem cell isolation

In a landmark 1998 paper published in the journal Science, Thomson announced the first successful isolation and culture of human embryonic stem cell lines. His team derived these cells from the inner cell mass of donated blastocysts produced through in vitro fertilization. This breakthrough provided scientists with a limitless, self-renewing source of human cells capable of differentiating into any cell type in the body, such as neurons, cardiomyocytes, and pancreatic islets. The achievement ignited both immense scientific excitement and significant ethical debate, influencing policy discussions at the highest levels of the U.S. government.

Induced pluripotent stem cell work

In 2007, building on the earlier discovery by Shinya Yamanaka in mouse cells, Thomson and his team simultaneously with Yamanaka's group reported the creation of human induced pluripotent stem cells. They reprogrammed adult human skin cells into an embryonic-like state by introducing specific transcription factors, including OCT4 and SOX2. This method bypassed the ethical controversies associated with human embryos and allowed for the creation of patient-specific stem cells. This work, also published in Science, earned him the co-recipient title of Time magazine's "Person of the Year" in 2008 and shared the prestigious Shaw Prize.

Awards and honors

Thomson's contributions have been recognized with numerous major awards. He is a member of the National Academy of Sciences and the National Academy of Medicine. His honors include the Albany Medical Center Prize, the Massry Prize, and the King Faisal International Prize in Medicine. He shared the 2011 Shaw Prize in Life Science and Medicine with Shinya Yamanaka and Rudolf Jaenisch. In 2012, he was awarded the prestigious March of Dimes Prize in Developmental Biology alongside Elaine Fuchs.

Personal life

Thomson maintains a relatively private personal life. He is married and has children. He continues his research in Madison, Wisconsin, serving as the director of regenerative biology at the Morgridge Institute for Research and as a professor at the University of Wisconsin–Madison. Beyond his laboratory, he has co-founded several biotechnology companies, including Cellular Dynamics International, which was later acquired by Fujifilm, to advance the commercial and therapeutic applications of stem cell technologies.

Category:American biologists Category:Stem cell researchers Category:University of Wisconsin–Madison faculty Category:1958 births Category:Living people